Stock listing
NASDAQ:VERV Verve Therapeutics Inc Stock
Follow Verve Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:VERV
$11.13 USD
Close on Jul 25, 2025 · No longer trades
- Lowest – highest close
- $2.97 – $73.99 USDSince Jun 17, 2021 · lowest Apr 8, 2025 · highest Sep 10, 2021
Delisted NASDAQ:VERV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:VERV
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alexander Cumbo Other companies: Stoke Therapeutics, Inc. (Director · Since at least Sep 23, 2026); Vor Biopharma Inc. (Chair of the Compensation Committee · Since at least Jul 16, 2025); Climb Bio, Inc. (Director · Since at least Mar 28, 2025); Solid Biosciences Inc. (President and CEO, Director · Since at least Dec 2, 2022); Ra Pharmaceuticals Inc (Director · Nov 14, 2018 – Apr 2, 2020 · Past); Sarepta Therapeutics, Inc. (EVP, Chief Commercial Officer · Mar 5, 2018 – Feb 28, 2020 · Past) | Director · Since at least Jun 9, 2022 |
| Allison Dorval Other companies: Puma Biotechnology Inc (Director · Since at least Jul 15, 2021); Jade Biosciences, Inc. (Director · Jul 15, 2021 – Jun 5, 2024 · Past); Voyager Therapeutics, Inc. (Chief Financial Officer · Jun 8, 2018 – Mar 19, 2021 · Past); Insulet Corporation (Chief Financial Officer · Nov 6, 2014 – Apr 1, 2015 · Past) | Chief Financial Officer · Since at least Nov 29, 2021 |
| Lonnel Coats Other companies: Mineralys Therapeutics, Inc. (Board Member · Since at least Oct 19, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Blueprint Medicines Corp (Director · Since at least Feb 3, 2016); Lexicon Pharmaceuticals, Inc. (Chief Executive Officer, Director · Jul 7, 2014 – Feb 28, 2024 · Past) | Director · Since at least Aug 8, 2022 |
| Krishna Yeshwant Other companies: Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past); Foundation Medicine Inc (Director · Jun 16, 2016 – Jul 31, 2018 · Past) | Director · Since at least Jun 16, 2021 |
| Michael MacLean Other companies: Research Alliance Corporation III (Director · Since at least May 19, 2026); CAMP4 Therapeutics Corporation (Director · Since at least Mar 24, 2026); Avidity Biosciences, Inc (Chief Financial Officer · Since at least Aug 6, 2025) | Director · Since at least Jun 5, 2025 |
| Fred T Fiedorek Other companies: Rhythm Pharmaceuticals, Inc. (Chief Medical Officer · Oct 4, 2017 – Feb 14, 2018 · Past) | Chief Medical Officer · Sep 18, 2023 – Feb 14, 2024 · Past |
| Andrew Bellinger | Chief Scientific Officer · Jun 16, 2021 – Feb 14, 2024 · Past |
| Andrew D Ashe | See Remarks · Since at least Apr 1, 2025 |
| Burt A Adelman | Director · Since at least Jun 5, 2025 |
| Jason Politi | Chief Technical Ops. Off. · Since at least Jun 26, 2024 |
All 12 people
| Person | Seat |
|---|---|
| Joan Nickerson | Chief Administrative Officer · Since at least Apr 1, 2025 |
| Troy Lister | Chief Scientific Officer · Since at least Jun 21, 2024 |
Log in to ask 6ix AI your own questions about Verve Therapeutics Inc.